ATP2B4 and breast carcinoma: In the present study we show that PMCA4(b) (assessed by a PMCA4-specific antibody) is downregulated in luminal-type breast carcinoma tissue samples, and that the expression level of the ATP2B4 gene correlates with patient survival.